SCHEMBL20857060

SCHEMBL20857060

O=C(c1cccc(N2CCOCC2)c1)N1CCC(N(C(=O)CCl)c2ccccc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.52
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 4/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MITF O75030 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
PAX8 Q06710 1/20 0.48
MGLL Q99685 1/20 0.48
MAPT P10636 3/20 0.47
USP2 O75604 2/20 0.47
MAPK1 P28482 2/20 0.47
LMNA P02545 2/20 0.47
TSHR P16473 1/20 0.47
PLOD2 O00469 1/20 0.44
PLOD3 O60568 1/20 0.44
PLOD1 Q02809 1/20 0.44
L3MBTL3 Q96JM7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18763050 0.83 MITF (0.64) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL19687605 0.82 MITF (0.54) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL18763041 0.79 MITF (0.51) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL20857035 0.79 MITF (0.66) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL18790577 0.79 KDM4E (0.51) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL18790578 0.79 KDM4E (0.51) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL20857033 0.78 KMT2A (0.49) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL18770884 0.76 MITF (0.71) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL4831334 0.76 KMO (0.72) KMOKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL5992407 0.75 ALDH1A1 (0.73) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF SCRIPPS RESEARCH INST (US) 2020-09-03 US disclosed
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF SCRIPPS RESEARCH INST (US) 2020-09-03 US disclosed
EP-3688472-A1 CONJUGATED PROTEINS AND USES THEREOF The Scripps Research Institute (US) 2020-08-05 EP disclosed
WO-2019067741-A1 CONJUGATED PROTEINS AND USES THEREOF THE SCRIPPS RESEARCH INSTITUTE (US) 2019-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF KEAP1, GSTK1, GSTM2 KMO 3675/4885ALDH1A1 1225/4885KDM4E 4173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.